Digital repository of Slovenian research organisations

Search the repository
A+ | A- | Help | SLO | ENG

There are two search modes available: simple and advanced. Simple search can include one or more words from the title, summary, keywords or full text, but does not allow the use of search operators. Advanced search allows to limit the number of search results by entering the search terms of different categories in the search window, as well as the use of Boolean search operators (AND, OR and AND NOT). In search results short formats of records are displayed and some data are displayed as links, which open a detailed description of the material (title link) or perform a new search (author or keyword link).

Help
Search in:
Options:
 


1241 - 1250 / 2000
First pagePrevious page121122123124125126127128129130Next pageLast page
1241.
Genetic polymorphisms of xenobiotic metabolizing enzymes in human colorectal cancer
Vita Dolžan, Metka Ravnik-Glavač, Katja Breskvar, 1998, published scientific conference contribution

Abstract: It was proposed that both hereaditary and environmental factors contribute to the development of colorectal cancer (CRC). Carcinogenic polycyclic aromatic hydrocarbons (PAHs) from food or tobacco smoke can form DNA adducts and thus initiate carcinogenesis after metabolic activation via cytochrome P4501A1 (CYP1A1). Intermediate metabolites are detoxified by conjugation with glutathione S-transferases. Our aim was to look for inherited metabolic suceptibility to CRC. We used PCR-based genotyping approach to determine the frequencies of polymorphic alleles of two cytochromes P450 (CYP2D6 and CYP1A1)and two glutathione S-transferases (GSTM1 and GSTT1) in DNA samples from 31 sporadic, 25 familial CRC cases and 73 healthy controls. The difference in frequencies of poor metabolisers due to CYP2D6 gene polymorphismwas close to the limit of statistical significance between sporadiCRC and healthy control group (lambda 2=5.52, m=2, p=0.06) despite the small sample size. The frequencies of either CYP1A1 MspI, GST M1 or GST T1 genotypes were not significantly different in both CRC cases and in controls. Although our study suggests some difference in metabolic susceptibility between sporadic and familial CRC, further studies are needed to investigate the combined effect of polymorphic genes involved in carcinogen metabolism in a larger group of patients with defined exposure to dietary carcinogens and smoking.
Published in DiRROS: 19.01.2024; Views: 314; Downloads: 81
.pdf Full text (1,37 MB)

1242.
1243.
1244.
On mechanisms of cell plasma membrane vesiculation
Veronika Kralj-Iglič, Urška Batista, Henry Hägerstrand, Aleš Iglič, Janja Majhenc, Mihael Sok, 1998, original scientific article

Keywords: budding, membrane bilayer, vesiculation
Published in DiRROS: 19.01.2024; Views: 234; Downloads: 79
.pdf Full text (1,68 MB)

1245.
The number of mitoses in simple and complex type carcinomas of the mammary gland in dogs
Polona Juntes, 1998, original scientific article

Published in DiRROS: 19.01.2024; Views: 217; Downloads: 57
.pdf Full text (1,30 MB)

1246.
1247.
Vinblastine increases antitumor effectiveness of bleomycin
Maja Čemažar, Marija Auersperg, Gregor Serša, 1997, original scientific article

Abstract: In our previous vinblastine (VELBE) was shown to increase the plasma membrane fluidity. This effect of VELBE might be expolited for better transport of drugs through the plasma membrane. Bleomycin (BLM) is a highly cytotoxic drug when present inside the cells but has a hampered transport through the plasma membrane. The aim of the present study was to determine whether pretreatment with VELBE can increase the effect of BLM on intraperitoneal SA-1 tumors in mice. BLM and VELBE were used as single agents or in various combinations, i.e. VELBE and BLM injected simultanously, BLM injected 24 h before VELBE or VELBE injected 24 h before BLM. Mice survival was the end-point used for determining the effect of this combined treatments. VELBE and BLM as a single treatment significantly prolonged median survival time of study animals compared to controls. Furthermore, when VELBE and BLM were combined, all threetested combinations were more effective than VELBE or BLM as single treatments. The effect on animal survival was equal when VELBE was given 24 h after or simultanously with BLM. The longest survival, however was obtained when VELBE was injected 24 h before BLM. From these results we can conclude that the underlying mechanisms for more than additive effect of VELBE and BLM when VELBE was given 24 h before BLM could be attributed to an increased membrane fluidity, possibly in combination with a cell kinetic effect.
Published in DiRROS: 18.01.2024; Views: 226; Downloads: 59
.pdf Full text (1,28 MB)

1248.
Long term follow-up after radiosynovectomy with yttrium 90 in patients with different rheumatic diseases
Mojca Golja, Nataša Budihna, Igor Batagelj, 1997, original scientific article

Abstract: The aim of the retrospective study was to evaluate the efficacy of radiosynovectomy (with yttrium 90) mainly in patients with rheumatoid arthritis, less with some other rheumatic diseases. The evaluation period varied from half to nine years. The procedure was performed in 273 patients (225 females, 48 males) or in 463 joints (402 knees, 61 shoulders and ankles).The effects was evaluated by change in degree of morning stiffiness, pain and swelling (score from 0 to 9). Very good results were obtained in 69 (15%), good in 142 (30.5%), moderate in 197 (42.5%) and no effect in 55 (12%) joints. Six months after the procedure 38 joints (8%), half to two years after221 joint (48%) were in good remission, after 3 to 4 years 95 joints (20%), after 5 to 6 years 57 joints (12%) were well, 7 to 9 years later 52 joints (11%) showed no signs of arthritis. Joint pain and swelling were the most frequent procedure complications (5.6%). In two patients with additional immunomodulating therapy chronic myeloid and lymphocityc leukaemia were diagnosed. Radiosynovectomy is considered to be an effective and safe treatment for synovitis indifferent rheumatic diseases.
Published in DiRROS: 18.01.2024; Views: 309; Downloads: 70
.pdf Full text (940,70 KB)

1249.
Cytology of mediastinal tumors
Milivoj Mermolja, Izidor Kern, Marjeta Terčelj-Zorman, Marjan Jereb, 1997, original scientific article

Abstract: Our experience with cytological examinations of tumorous mediastinal lesions is evaluated. A group of 117 patients with mediastinal tumor have been included into the study. Among them carcinomas prevailed (60,7%), followed by lymphomas (18,8%), other tumors (15.4%) and thymic neoplasms (5.1%). Malignantor suspicious cells were found in 77.4% of patients with carcinoma. The cells indicating a possibility of non-Hodgkin's lymphoma were found in 9 out of 14 patients. In 5 out of 6 thymic neoplasms the cytological pattern wasconsistent with the diagnosis of thymic neoplasm. One case of thymoma was cytologically falsely diagnosed as malignant lymphoma. One case of neurofibroma was falsely diagnosed as adenocarcinoma. The sensitivity of cytological examinations was 67.5%. If 18 patients with diagnostically unsatisfactory material were excluded from the analysis, the sensitivity wouldincrease to 80.8%. Owing to the wide variety of primary and metastatic tumors that can occur in the mediastinum, apart from the routine cytological techniques, additional staining methods should be used. For final cytological diagnosis the integration of cytological findings with clinical and radiological data is often required. Owing to the characteristics of the obtained material and biological behaviour of some mediastinal tumors, some tumors cannot be definitively diagnosed by cytological examinations alone.
Published in DiRROS: 18.01.2024; Views: 332; Downloads: 83
.pdf Full text (1,10 MB)

1250.
Brachytherapy (Ru 106) in the treatment of malignant melanoma of the choroid
Boris Jančar, K... Andrejčič, Primož Logar, Irena-Hedvika Brovet-Zupančič, 1997, published scientific conference contribution abstract

Published in DiRROS: 18.01.2024; Views: 253; Downloads: 66
.pdf Full text (1,10 MB)

Search done in 0.62 sec.
Back to top